📰 Director Daniel News
Page 41 - Director Daniel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Director Daniel. Real-time updates on events, politics, business and more.
January 5, 2024
Kowal Investment Group LLC lowered its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,843 shares of the healthcare product maker’s stock after selling 479 shares during the period. Kowal Investment Group […]
January 5, 2024
Super Micro Computer, Inc. (NASDAQ:SMCI – Get Free Report) Director Daniel W. Fairfax sold 300 shares of the stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $280.00, for a total value of $84,000.00. Following the completion of the sale, the director now owns 20,387 shares in […]
January 5, 2024
Kowal Investment Group LLC trimmed its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 3.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,843 shares of the healthcare product maker’s stock after selling 479 shares during the quarter. Kowal Investment […]
January 5, 2024
Silver Lake Advisory LLC grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 48,376 shares of the healthcare product maker’s stock after buying an additional 1,175 shares during the quarter. Abbott […]
January 5, 2024
Smithbridge Asset Management Inc. DE lifted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 45,393 shares of the healthcare product maker’s stock after acquiring an additional 513 shares during […]
January 5, 2024
Sage Mountain Advisors LLC lessened its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 3.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,480 shares of the healthcare product maker’s stock after selling 293 shares during the […]
January 5, 2024
OLD Second National Bank of Aurora lowered its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 5.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 30,942 shares of the healthcare product maker’s stock after selling 1,699 shares during the […]
January 5, 2024
Smithbridge Asset Management Inc. DE grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 45,393 shares of the healthcare product maker’s stock after buying an additional 513 shares during the period. Smithbridge Asset Management […]
January 4, 2024
Patton Albertson Miller Group LLC grew its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 12.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,119 shares of the healthcare product maker’s stock after buying an additional 1,381 shares during the period. Patton Albertson […]
January 4, 2024
Bank of New York Mellon Corp reduced its position in Abbott Laboratories (NYSE:ABT – Free Report) by 3.8% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 14,603,003 shares of the healthcare product maker’s stock after selling 569,235 shares during the period. Bank of New York Mellon Corp […]